KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alnylam Pharmaceuticals (ALNY) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for Alnylam Pharmaceuticals (ALNY) over the last 9 years, with Q4 2025 value amounting to $0.82.

  • Alnylam Pharmaceuticals' EPS (Weighted Average and Diluted) rose 22615.38% to $0.82 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.01, marking a year-over-year increase of 19262.67%. This contributed to the annual value of $2.33 for FY2025, which is 20688.07% up from last year.
  • According to the latest figures from Q4 2025, Alnylam Pharmaceuticals' EPS (Weighted Average and Diluted) is $0.82, which was up 22615.38% from $1.84 recorded in Q3 2025.
  • In the past 5 years, Alnylam Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of $1.84 during Q3 2025, and its lowest value of -$3.32 during Q3 2022.
  • Over the past 5 years, Alnylam Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$1.24 (recorded in 2023), while the average stood at -$1.01.
  • Examining YoY changes over the last 5 years, Alnylam Pharmaceuticals' EPS (Weighted Average and Diluted) showed a top increase of 31149.43% in 2025 and a maximum decrease of 29230.77% in 2025.
  • Over the past 5 years, Alnylam Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$2.18 in 2021, then increased by 21.86% to -$1.71 in 2022, then soared by 36.07% to -$1.09 in 2023, then surged by 40.37% to -$0.65 in 2024, then surged by 226.15% to $0.82 in 2025.
  • Its last three reported values are $0.82 in Q4 2025, $1.84 for Q3 2025, and -$0.51 during Q2 2025.